These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162 [TBL] [Abstract][Full Text] [Related]
13. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Badimon JJ; Lettino M; Toschi V; Fuster V; Berrozpe M; Chesebro JH; Badimon L Circulation; 1999 Apr; 99(14):1780-7. PubMed ID: 10199872 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488 [TBL] [Abstract][Full Text] [Related]
15. The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis. Jiang P; Xue D; Zhang Y; Ye L; Liu Y; Makale M; Kesari S; Edgington TS; Liu C Thromb Res; 2014 Apr; 133(4):657-66. PubMed ID: 24485401 [TBL] [Abstract][Full Text] [Related]
16. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study. Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291 [TBL] [Abstract][Full Text] [Related]
17. Tissue factor and tissue factor pathway inhibitor in nasal mucosa and nasal secretions of chronic rhinosinusitis with nasal polyp. Shimizu S; Ogawa T; Takezawa K; Tojima I; Kouzaki H; Shimizu T Am J Rhinol Allergy; 2015; 29(4):235-42. PubMed ID: 26163243 [TBL] [Abstract][Full Text] [Related]
18. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins. Zawadzki C; Susen S; Richard F; Haulon S; Corseaux D; Jeanpierre E; Vincentelli A; Lucas C; Torpier G; Martin A; Van Belle E; Staels B; Jude B Atherosclerosis; 2007 Dec; 195(2):e117-25. PubMed ID: 17196206 [TBL] [Abstract][Full Text] [Related]